A detailed history of Mitsubishi Ufj Trust & Banking Corp transactions in Biogen Inc. stock. As of the latest transaction made, Mitsubishi Ufj Trust & Banking Corp holds 79,171 shares of BIIB stock, worth $12.5 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
79,171
Previous 78,627 0.69%
Holding current value
$12.5 Million
Previous $18.2 Million 15.81%
% of portfolio
0.04%
Previous 0.04%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$189.07 - $236.8 $102,854 - $128,819
544 Added 0.69%
79,171 $15.3 Million
Q2 2024

Aug 08, 2024

BUY
$190.52 - $236.72 $109,358 - $135,877
574 Added 0.74%
78,627 $18.2 Million
Q1 2024

May 10, 2024

SELL
$212.02 - $267.71 $1.33 Million - $1.67 Million
-6,254 Reduced 7.42%
78,053 $16.8 Million
Q4 2023

Feb 09, 2024

SELL
$222.59 - $267.94 $2.77 Million - $3.34 Million
-12,466 Reduced 12.88%
84,307 $21.8 Million
Q3 2023

Nov 09, 2023

SELL
$253.3 - $285.89 $308,772 - $348,499
-1,219 Reduced 1.24%
96,773 $24.9 Million
Q2 2023

Aug 08, 2023

SELL
$275.25 - $318.06 $8.31 Million - $9.61 Million
-30,202 Reduced 23.56%
97,992 $27.9 Million
Q1 2023

May 10, 2023

SELL
$256.56 - $292.34 $7.28 Million - $8.3 Million
-28,381 Reduced 18.13%
128,194 $35.6 Million
Q4 2022

Feb 10, 2023

SELL
$252.44 - $306.72 $3.46 Million - $4.21 Million
-13,721 Reduced 8.06%
156,575 $43.4 Million
Q3 2022

Nov 10, 2022

BUY
$194.69 - $268.46 $1.11 Million - $1.53 Million
5,713 Added 3.47%
170,296 $45.5 Million
Q2 2022

Aug 09, 2022

BUY
$187.54 - $223.02 $2.14 Million - $2.55 Million
11,432 Added 7.46%
164,583 $33.6 Million
Q1 2022

May 12, 2022

SELL
$193.77 - $244.14 $1.67 Million - $2.11 Million
-8,630 Reduced 5.33%
153,151 $32.3 Million
Q4 2021

Feb 09, 2022

SELL
$223.92 - $287.77 $5.39 Million - $6.93 Million
-24,082 Reduced 12.96%
161,781 $38.8 Million
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $4.21 Million - $5.49 Million
-14,872 Reduced 7.41%
185,863 $52.6 Million
Q2 2021

Aug 12, 2021

SELL
$259.0 - $414.71 $6.82 Million - $10.9 Million
-26,316 Reduced 11.59%
200,735 $69.5 Million
Q1 2021

May 12, 2021

SELL
$242.95 - $284.63 $1.03 Million - $1.21 Million
-4,253 Reduced 1.84%
227,051 $59.6 Million
Q4 2020

Feb 12, 2021

BUY
$236.26 - $355.63 $30,241 - $45,520
128 Added 0.06%
231,304 $56.6 Million
Q3 2020

Nov 12, 2020

BUY
$264.77 - $305.71 $1.66 Million - $1.92 Million
6,266 Added 2.79%
231,176 $65.6 Million
Q2 2020

Sep 11, 2020

BUY
$258.66 - $342.55 $9.56 Million - $12.7 Million
36,955 Added 19.66%
224,910 $60.2 Million
Q2 2020

Aug 13, 2020

SELL
$258.66 - $342.55 $7.58 Million - $10 Million
-29,294 Reduced 13.48%
187,955 $60.2 Million
Q1 2020

May 13, 2020

BUY
$268.85 - $341.04 $2.59 Million - $3.28 Million
9,623 Added 4.63%
217,249 $68.7 Million
Q4 2019

Feb 14, 2020

BUY
$220.06 - $304.07 $554,771 - $766,560
2,521 Added 1.23%
207,626 $61.6 Million
Q3 2019

Nov 12, 2019

BUY
$217.44 - $243.88 $4.93 Million - $5.53 Million
22,661 Added 12.42%
205,105 $47.3 Million
Q2 2019

Aug 07, 2019

BUY
$219.29 - $241.72 $1.19 Million - $1.31 Million
5,420 Added 3.06%
182,444 $43.7 Million
Q1 2019

May 13, 2019

SELL
$216.71 - $338.96 $318,346 - $497,932
-1,469 Reduced 0.82%
177,024 $41.2 Million
Q4 2018

Feb 12, 2019

BUY
$278.5 - $352.75 $104,994 - $132,986
377 Added 0.21%
178,493 $53.7 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $78.6 Million - $103 Million
-267,822 Reduced 60.06%
178,116 $62.9 Million
Q2 2018

Aug 10, 2018

BUY
$257.52 - $306.91 $2.08 Million - $2.48 Million
8,073 Added 1.84%
445,938 $129 Million
Q1 2018

May 11, 2018

BUY
$260.13 - $367.91 $1.04 Million - $1.47 Million
4,009 Added 0.92%
437,865 $120 Million
Q4 2017

Feb 09, 2018

SELL
$307.64 - $344.58 $3.57 Million - $4 Million
-11,609 Reduced 2.61%
433,856 $138 Million
Q3 2017

Nov 13, 2017

BUY
$281.15 - $329.69 $125 Million - $147 Million
445,465
445,465 $139 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.7B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Mitsubishi Ufj Trust & Banking Corp Portfolio

Follow Mitsubishi Ufj Trust & Banking Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Trust & Banking Corp, based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Trust & Banking Corp with notifications on news.